Company Directory > CRO > SSI Strategy
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SSI Strategy and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR

SSI Strategy

Parsippany, New Jersey, USA
VISIT WEBSITE
SSI Strategy is a boutique management consulting firm that provides strategic support to life sciences companies, specifically focusing on Medical Affairs, Clinical Development, and Pharmacovigilance. The firm is known for its adaptive model of embedding seasoned executives and operators directly into biotech organizations to accelerate drug development, reduce risk, and maximize therapeutic value from pre-clinical stages through to product launch. In September 2025, the company was acquired by Clinigen, a global organization specializing in clinical trial supply, managed access, and commercialization. SSI Strategy continues to operate with its established leadership team, leveraging its deep expertise in rare diseases and innovative therapeutic pathways to support a client base of over 280 biopharma companies.
CLASSIFICATION
Company Type:CRO
Industry:CRO
Sub-Industry:Strategic Consulting / Life Sciences Outsourcing
SIZE & FINANCIALS
Employees:51-200
Founded:2010
Ownership:subsidiary
Status:acquired
FUNDING
Investors:Amulet Capital Partners
PIPELINE
Modalities:Small molecule, Biologics, Cell therapy, Gene therapy, Digital medicine
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Clinigen
Acquired By:Clinigen (2025-09-01)
Key Partnerships:Clinigen (Parent Company), BioIndustry Association (Member), Digital Therapeutics Alliance (Member)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Doug Locke - CEO
Adam Schwartz - President
Kim Kushner - Chief Business Officer
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SSI Strategy. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.